journal article·2025-01Open access

Biocompatible Zn‐Phthalocyanine/Gelatin Nanofiber Membrane for Antibacterial Therapy

Romina Clementi, Maria Angela Vargas, Mariana Cid, Nancy Salvatierra, Romina Comín, Tomas Tempesti

Macromolecular Bioscience· Volume 25· Issue 1

Abstract

Abstract In this study, the fabrication and characterization of Zn‐phthalocyanine/gelatin nanofibrous membranes is reported using the electrospinning technique. The membranes exhibit a homogeneous distribution of Zn‐phthalocyanine within the gelatin matrix, maintaining the structural integrity and photosensitizing properties of the phthalocyanine. Scanning electron microscopy revealed that the electrospun fibers possess diameters ranging results as 100–300, 200–700, and 300–800 nm for Gel, ZnPc/Gel 1, and ZnPc/Gel 2, respectively. The addition of ZnPc does not decrease the hydrophilicity of the Gel membrane. The nanofibrous membranes showed good cytocompatibility, as indicated by the high viability of Vero cells exposed to membrane extracts. Furthermore, these composites supported cell adhesion and proliferation on their surfaces. The two Zn‐phthalocyanine/gelatin nanofiber formulations exhibited significant antimicrobial activity toward Escherichia Coli (E. Coli) and Staphylococcus Aureus (S. Aureus) under visible light illumination, achieving reductions of 3.4 log10 and 3.6 log10 CFU mL−1 for E. coli, and 3.9 log10 and 4.1 log10 CFU mL−1 for S. aureus. These results demonstrate the potential of Zn‐phthalocyanine/gelatin nanofibrous membranes as effective agents in antibacterial photodynamic therapy, providing a promising solution to control bacterial infections and antibiotic resistance.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departamento de Química Orgánica Facultad de Ciencias Químicas Universidad Nacional de Córdoba Ciudad Universitaria Córdoba X5000HUA Argentina

Laboratorio de Microbiología Hospital Provincial Florencio Diaz Córdoba Argentina

Facultad Ciencias Exactas Físicas y Naturales Departamento de Química Universidad Nacional de Córdoba Av. Vélez Sarsfield 1611 Córdoba 5016 Argentina

CONICET Instituto de Investigaciones Biológicas y Tecnológicas (IIByT) Córdoba Argentina

INFIQC‐CONICET Instituto de Investigaciones en Físico‐Química de Córdoba Córdoba Argentina

Funding

Consejo Nacional de Investigaciones Científicas y Técnicas · Universidad Nacional de Córdoba · Fondo para la Investigación Científica y Tecnológica

References (43)

Show source-provided references
1. 10.1111/j.1469-0691.2008.02126.x10.1111/j.1469-0691.2008.02126.x ↗
2. WHO Antimicrobial resistance: global report on surveillance World Health Organization2021 https://www.who.int/publications/i/item/9789240027336 (accessed: October 2024).
3. Lazovski J. · Rev. Panam. Salud. Publica. · 2017 · 41
4. 10.4155/fmc-2018-032910.4155/fmc-2018-0329 ↗
5. 10.1039/c8pp00534f10.1039/c8pp00534f ↗
6. 10.3390/ijms16092052310.3390/ijms160920523 ↗
7. 10.1002/adfm.20230814510.1002/adfm.202308145 ↗
8. 10.1042/BJ2015094210.1042/BJ20150942 ↗
9. 10.1016/j.canlet.2012.07.02610.1016/j.canlet.2012.07.026 ↗
10. 10.1039/c4pp00315b10.1039/c4pp00315b ↗
11. 10.1016/j.ccr.2016.06.00710.1016/j.ccr.2016.06.007 ↗
12. 10.3390/ijms2502102310.3390/ijms25021023 ↗
13. Valle‐Molinares R. H. · Pharmacologyoneline · 2015 · 2 · 131
14. 10.1016/j.bmcl.2017.08.02810.1016/j.bmcl.2017.08.028 ↗
15. 10.1186/1556-276X-8-10210.1186/1556-276X-8-102 ↗
16. 10.1088/0957-4484/7/3/00910.1088/0957-4484/7/3/009 ↗
17. 10.1016/0304-3886(95)00041-810.1016/0304-3886(95)00041-8 ↗
18. 10.1002/jbm.1016710.1002/jbm.10167 ↗
19. 10.1155/2013/78928910.1155/2013/789289 ↗
20. 10.3390/ijms2310544410.3390/ijms23105444 ↗
21. 10.1002/bit.2151710.1002/bit.21517 ↗
22. 10.3390/nano804019910.3390/nano8040199 ↗
23. 10.1007/s12221-022-4166-410.1007/s12221-022-4166-4 ↗
24. 10.1016/j.msec.2017.06.00110.1016/j.msec.2017.06.001 ↗
25. 10.1002/mabi.20210051210.1002/mabi.202100512 ↗
26. 10.1016/j.bioactmat.2022.08.01110.1016/j.bioactmat.2022.08.011 ↗
27. 10.1007/s10973-021-10851-x10.1007/s10973-021-10851-x ↗
28. Galstyan A. · Nanoscale Adv. · 2021 · 9 · 200
29. 10.1039/b007763l10.1039/b007763l ↗
30. 10.1016/S0022-2860(03)00155-810.1016/S0022-2860(03)00155-8 ↗
31. 10.1016/j.msec.2020.11093610.1016/j.msec.2020.110936 ↗
32. 10.1016/j.msec.2020.11106810.1016/j.msec.2020.111068 ↗
33. 10.1016/j.colsurfb.2016.03.08110.1016/j.colsurfb.2016.03.081 ↗
34. 10.1021/acs.jafc.8b0622610.1021/acs.jafc.8b06226 ↗
35. 10.1016/j.jphotobiol.2007.11.00210.1016/j.jphotobiol.2007.11.002 ↗
36. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
37. 10.1016/j.lwt.2023.11526110.1016/j.lwt.2023.115261 ↗
38. 10.1039/D4RA03803G10.1039/D4RA03803G ↗
39. 10.1038/s41598-019-39390-010.1038/s41598-019-39390-0 ↗
40. International Organization for Standardization Biological evaluation of medical devices. ISO 10993. Part 1: Evaluation and testing in the risk management process. Geneva Switzerland: International Organization for Standardization 2018.
41. International Organization for Standardization Biological evaluation of medical devices. ISO 10993. Part 12: Sample preparation and reference materials. Geneva Switzerland: International Organization for Standardization 2021.
42. 10.5301/jabfm.500034010.5301/jabfm.5000340 ↗
43. International Organization for Standardization Biological evaluation of medical devices. ISO 10993. Part 5: Tests for in vitro cytotoxicity. Geneva Switzerland: International Organization for Standardization 2009.